Yifeng Accounts Payable vs Other Current Assets Analysis

603939 Stock   23.42  0.12  0.52%   
Yifeng Pharmacy financial indicator trend analysis is more than just analyzing Yifeng Pharmacy current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Yifeng Pharmacy is a good investment. Please check the relationship between Yifeng Pharmacy Accounts Payable and its Other Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yifeng Pharmacy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Accounts Payable vs Other Current Assets

Accounts Payable vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Yifeng Pharmacy Accounts Payable account and Other Current Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Yifeng Pharmacy's Accounts Payable and Other Current Assets is 0.63. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Yifeng Pharmacy, assuming nothing else is changed. The correlation between historical values of Yifeng Pharmacy's Accounts Payable and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Yifeng Pharmacy are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Accounts Payable i.e., Yifeng Pharmacy's Accounts Payable and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.63
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents Yifeng Pharmacy obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Yifeng Pharmacy are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Most indicators from Yifeng Pharmacy's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Yifeng Pharmacy current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yifeng Pharmacy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Selling General Administrative is expected to grow to about 5.9 B, whereas Tax Provision is forecasted to decline to about 286.7 M.
 2021 2022 2023 2024 (projected)
Operating Income1.5B2.0B2.1B2.2B
Total Revenue15.3B19.9B22.6B23.7B

Yifeng Pharmacy fundamental ratios Correlations

0.421.00.990.330.990.961.00.981.00.661.00.860.980.970.990.890.80.481.00.570.930.920.310.90.71
0.420.380.430.190.360.570.440.350.470.610.410.660.430.410.340.630.42-0.40.410.410.550.540.190.63-0.14
1.00.380.980.331.00.960.990.980.990.621.00.840.960.971.00.860.780.480.990.530.920.920.270.890.73
0.990.430.980.320.980.950.990.980.990.720.980.870.990.940.980.890.810.510.990.620.920.910.350.890.68
0.330.190.330.320.330.330.310.330.340.230.340.410.270.310.330.380.380.130.350.230.420.410.090.360.36
0.990.361.00.980.330.950.990.990.990.631.00.830.960.961.00.860.780.50.990.530.910.910.260.870.74
0.960.570.960.950.330.950.970.920.970.680.960.890.940.960.940.910.750.340.960.570.940.910.380.950.59
1.00.440.990.990.310.990.970.970.990.670.990.860.980.970.990.880.810.471.00.610.930.920.370.910.69
0.980.350.980.980.330.990.920.970.980.680.980.820.950.920.990.850.770.50.980.570.90.890.250.830.73
1.00.470.990.990.340.990.970.990.980.690.990.880.970.960.990.910.790.420.990.570.930.940.290.920.67
0.660.610.620.720.230.630.680.670.680.690.620.830.670.510.620.840.50.110.650.840.710.660.50.650.33
1.00.411.00.980.341.00.960.990.980.990.620.850.960.981.00.870.790.461.00.520.920.930.270.90.72
0.860.660.840.870.410.830.890.860.820.880.830.850.830.810.820.970.780.20.850.650.960.930.360.930.58
0.980.430.960.990.270.960.940.980.950.970.670.960.830.940.960.860.820.520.970.610.90.890.370.880.66
0.970.410.970.940.310.960.960.970.920.960.510.980.810.940.960.820.810.440.970.460.910.910.280.920.68
0.990.341.00.980.331.00.940.990.990.990.621.00.820.960.960.840.80.520.990.530.910.910.260.870.75
0.890.630.860.890.380.860.910.880.850.910.840.870.970.860.820.840.730.210.870.640.950.930.390.940.6
0.80.420.780.810.380.780.750.810.770.790.50.790.780.820.810.80.730.440.810.530.870.880.220.780.7
0.48-0.40.480.510.130.50.340.470.50.420.110.460.20.520.440.520.210.440.470.270.360.250.330.210.62
1.00.410.990.990.350.990.961.00.980.990.651.00.850.970.970.990.870.810.470.570.920.930.30.90.71
0.570.410.530.620.230.530.570.610.570.570.840.520.650.610.460.530.640.530.270.570.60.520.770.530.33
0.930.550.920.920.420.910.940.930.90.930.710.920.960.90.910.910.950.870.360.920.60.970.350.950.72
0.920.540.920.910.410.910.910.920.890.940.660.930.930.890.910.910.930.880.250.930.520.970.220.950.73
0.310.190.270.350.090.260.380.370.250.290.50.270.360.370.280.260.390.220.330.30.770.350.220.380.18
0.90.630.890.890.360.870.950.910.830.920.650.90.930.880.920.870.940.780.210.90.530.950.950.380.6
0.71-0.140.730.680.360.740.590.690.730.670.330.720.580.660.680.750.60.70.620.710.330.720.730.180.6
Click cells to compare fundamentals

Yifeng Pharmacy Account Relationship Matchups

Yifeng Pharmacy fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets9.2B12.9B17.1B21.0B24.1B25.3B
Other Current Liab321.2M525.1M672.4M1.0B22.6M21.5M
Total Current Liabilities3.7B5.9B6.7B9.7B11.3B11.8B
Total Stockholder Equity4.5B5.5B7.5B8.6B9.8B10.3B
Other Liab54.1M53.9M52.5M78.4M90.2M48.4M
Accounts Payable3.0B3.8B4.8B6.8B8.2B8.6B
Cash1.4B3.4B2.9B4.1B3.6B3.7B
Other Assets239.8M400.0M517.8M568.5M653.7M686.4M
Net Receivables953.0M830.3M1.1B1.8B2.1B2.2B
Inventory1.8B2.2B3.0B3.6B3.8B4.0B
Other Current Assets547.5M341.7M356.7M466.0M384.1M298.8M
Total Liab4.5B7.2B9.2B11.9B13.7B14.4B
Intangible Assets355.1M375.3M396.5M485.5M474.5M271.2M
Common Stock378.9M531.5M718.8M721.7M830.0M871.5M
Property Plant Equipment528.0M3.6B4.5B4.9B5.6B5.9B
Retained Earnings1.5B2.1B2.8B3.9B4.8B5.0B
Good Will3.0B3.3B3.7B4.2B4.6B2.6B
Net Tangible Assets1.1B1.7B3.4B3.9B4.5B2.3B
Short Term Investments193.2M744.8M152.2M50.0M1.6B1.7B
Deferred Long Term Liab207.0M267.4M379.6M430.7M495.3M520.1M
Total Current Assets5.0B7.7B7.9B10.6B12.1B6.8B
Non Current Assets Total4.2B4.9B9.1B10.5B12.0B6.4B
Non Currrent Assets Other12.2M58.4M28.4M7.2M30.3M23.9M
Non Current Liabilities Total741.3M2.0B2.4B2.3B2.4B1.5B
Common Stock Shares Outstanding689.6M691.0M718.8M721.7M1.2B845.4M
Net Invested Capital5.2B7.8B7.8B8.8B9.9B7.5B
Net Working Capital1.3B2.9B1.2B918.9M859.4M1.2B
Long Term Debt687.2M2.0B365.6M228.7M133.6M126.9M
Capital Stock378.9M531.5M718.8M721.7M1.0B685.4M

Currently Active Assets on Macroaxis

Other Information on Investing in Yifeng Stock

Balance Sheet is a snapshot of the financial position of Yifeng Pharmacy at a specified time, usually calculated after every quarter, six months, or one year. Yifeng Pharmacy Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Yifeng Pharmacy and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Yifeng currently owns. An asset can also be divided into two categories, current and non-current.